Under normal physiological conditions, chemical and antioxidant defenses pr
otect tissues from the damaging effects of reactive oxygen metabolites (ROM
). It has been proposed that ROMs are involved in the development of tissue
injury in many inflammatory diseases and also in patients with colitis. In
the present study we aimed to investigate the effects of antioxidant thera
py on the extent of colonic inflammation and ROM levels in the injured tiss
ues in a trinitrobenzene sulfonic acid-induced colitis model in the rat. Sp
rague-Dawley rats were pretreated with the antioxidants superoxide dismutas
e (30,000 U/kg s.c.) or catalase (400,000 U/kg s.c.) prior to induction of
colitis and they were decapitated 24 h (acute group) or 6 days (chronic gro
up) after the induction of colitis (each group consists of eight to ten rat
s). Pretreatment with the antioxidants reduced the macroscopic damage score
significantly in both acute and chronic groups compared with untreated col
itis groups, whereas they reduced the microscopic damage score and colonic
wet weight only in the chronic group. The chemiluminescence assay - a techn
ique to assess the presence of reactive oxygen species in the tissues - val
ues of the groups pretreated with the antioxidants showed a tendency to dec
rease compared with the untreated colitis group, but they were not statisti
cally significant. Based on these findings, pretreatment with the antioxida
nts superoxide dismutase or catalase has beneficial effects on the extent o
f colonic inflammation, particularly in the chronic period, and this may su
pport the importance of antioxidant therapy to reduce the severity of infla
mmatory bowel disease in humans.